Su1465 Elevated Serum Uric Acid Level Was a Notable Adverse Event of the Combination Therapy With Sofosbuvir and Ribavirin
Gespeichert in:
| Autor*in: |
Sato, Ken [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|
| Erschienen: |
2016 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Ubiquitin protease Ubp8 is necessary for - Leo, Manuela ELSEVIER, 2018, official publication of the American Gastroenterological Association, Stanford, Calif |
|---|---|
| Übergeordnetes Werk: |
volume:150 ; year:2016 ; number:4 ; pages:1107 |
| Links: |
|---|
| DOI / URN: |
10.1016/S0016-5085(16)33742-8 |
|---|
| Katalog-ID: |
ELV014578417 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV014578417 | ||
| 003 | DE-627 | ||
| 005 | 20230623114632.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180602s2016 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1016/S0016-5085(16)33742-8 |2 doi | |
| 028 | 5 | 2 | |a GBVA2016021000021.pica |
| 035 | |a (DE-627)ELV014578417 | ||
| 035 | |a (ELSEVIER)S0016-5085(16)33742-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 570 |q VZ |
| 084 | |a BIODIV |q DE-30 |2 fid | ||
| 084 | |a 35.70 |2 bkl | ||
| 084 | |a 42.12 |2 bkl | ||
| 084 | |a 42.15 |2 bkl | ||
| 100 | 1 | |a Sato, Ken |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Su1465 Elevated Serum Uric Acid Level Was a Notable Adverse Event of the Combination Therapy With Sofosbuvir and Ribavirin |
| 264 | 1 | |c 2016 | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 700 | 1 | |a Naganuma, Atsushi |4 oth | |
| 700 | 1 | |a Nagashima, Tamon |4 oth | |
| 700 | 1 | |a Horiuchi, Katsuhiko |4 oth | |
| 700 | 1 | |a Hoshino, Takashi |4 oth | |
| 700 | 1 | |a Arai, Yosuke |4 oth | |
| 700 | 1 | |a Yuasa, Kazuhisa |4 oth | |
| 700 | 1 | |a Uehara, Daisuke |4 oth | |
| 700 | 1 | |a Hashizume, Hiroaki |4 oth | |
| 700 | 1 | |a Kobayashi, Takeshi |4 oth | |
| 700 | 1 | |a Ohyama, Tatsuya |4 oth | |
| 700 | 1 | |a Horiguchi, Norio |4 oth | |
| 700 | 1 | |a Yamazaki, Yuichi |4 oth | |
| 700 | 1 | |a Kakizaki, Satoru |4 oth | |
| 700 | 1 | |a Kusano, Motoyasu |4 oth | |
| 700 | 1 | |a Yamada, Masanobu |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n HighWire Press |a Leo, Manuela ELSEVIER |t Ubiquitin protease Ubp8 is necessary for |d 2018 |d official publication of the American Gastroenterological Association |g Stanford, Calif |w (DE-627)ELV000307017 |
| 773 | 1 | 8 | |g volume:150 |g year:2016 |g number:4 |g pages:1107 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/S0016-5085(16)33742-8 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a FID-BIODIV | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 35.70 |j Biochemie: Allgemeines |q VZ |
| 936 | b | k | |a 42.12 |j Biophysik |q VZ |
| 936 | b | k | |a 42.15 |j Zellbiologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 150 |j 2016 |e 4 |h 1107 |y 150.2016, 4, S1107- | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
k s ks |
|---|---|
| matchkey_str |
satokennaganumaatsushinagashimatamonhori:2016----:u45lvtdeuuiailvlaaoalavrevnoteobntoteay |
| hierarchy_sort_str |
2016 |
| bklnumber |
35.70 42.12 42.15 |
| publishDate |
2016 |
| allfields |
10.1016/S0016-5085(16)33742-8 doi GBVA2016021000021.pica (DE-627)ELV014578417 (ELSEVIER)S0016-5085(16)33742-8 DE-627 ger DE-627 rakwb 610 610 DE-600 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl Sato, Ken verfasserin aut Su1465 Elevated Serum Uric Acid Level Was a Notable Adverse Event of the Combination Therapy With Sofosbuvir and Ribavirin 2016 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Naganuma, Atsushi oth Nagashima, Tamon oth Horiuchi, Katsuhiko oth Hoshino, Takashi oth Arai, Yosuke oth Yuasa, Kazuhisa oth Uehara, Daisuke oth Hashizume, Hiroaki oth Kobayashi, Takeshi oth Ohyama, Tatsuya oth Horiguchi, Norio oth Yamazaki, Yuichi oth Kakizaki, Satoru oth Kusano, Motoyasu oth Yamada, Masanobu oth Enthalten in HighWire Press Leo, Manuela ELSEVIER Ubiquitin protease Ubp8 is necessary for 2018 official publication of the American Gastroenterological Association Stanford, Calif (DE-627)ELV000307017 volume:150 year:2016 number:4 pages:1107 https://doi.org/10.1016/S0016-5085(16)33742-8 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ 42.15 Zellbiologie VZ AR 150 2016 4 1107 150.2016, 4, S1107- 045F 610 |
| spelling |
10.1016/S0016-5085(16)33742-8 doi GBVA2016021000021.pica (DE-627)ELV014578417 (ELSEVIER)S0016-5085(16)33742-8 DE-627 ger DE-627 rakwb 610 610 DE-600 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl Sato, Ken verfasserin aut Su1465 Elevated Serum Uric Acid Level Was a Notable Adverse Event of the Combination Therapy With Sofosbuvir and Ribavirin 2016 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Naganuma, Atsushi oth Nagashima, Tamon oth Horiuchi, Katsuhiko oth Hoshino, Takashi oth Arai, Yosuke oth Yuasa, Kazuhisa oth Uehara, Daisuke oth Hashizume, Hiroaki oth Kobayashi, Takeshi oth Ohyama, Tatsuya oth Horiguchi, Norio oth Yamazaki, Yuichi oth Kakizaki, Satoru oth Kusano, Motoyasu oth Yamada, Masanobu oth Enthalten in HighWire Press Leo, Manuela ELSEVIER Ubiquitin protease Ubp8 is necessary for 2018 official publication of the American Gastroenterological Association Stanford, Calif (DE-627)ELV000307017 volume:150 year:2016 number:4 pages:1107 https://doi.org/10.1016/S0016-5085(16)33742-8 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ 42.15 Zellbiologie VZ AR 150 2016 4 1107 150.2016, 4, S1107- 045F 610 |
| allfields_unstemmed |
10.1016/S0016-5085(16)33742-8 doi GBVA2016021000021.pica (DE-627)ELV014578417 (ELSEVIER)S0016-5085(16)33742-8 DE-627 ger DE-627 rakwb 610 610 DE-600 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl Sato, Ken verfasserin aut Su1465 Elevated Serum Uric Acid Level Was a Notable Adverse Event of the Combination Therapy With Sofosbuvir and Ribavirin 2016 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Naganuma, Atsushi oth Nagashima, Tamon oth Horiuchi, Katsuhiko oth Hoshino, Takashi oth Arai, Yosuke oth Yuasa, Kazuhisa oth Uehara, Daisuke oth Hashizume, Hiroaki oth Kobayashi, Takeshi oth Ohyama, Tatsuya oth Horiguchi, Norio oth Yamazaki, Yuichi oth Kakizaki, Satoru oth Kusano, Motoyasu oth Yamada, Masanobu oth Enthalten in HighWire Press Leo, Manuela ELSEVIER Ubiquitin protease Ubp8 is necessary for 2018 official publication of the American Gastroenterological Association Stanford, Calif (DE-627)ELV000307017 volume:150 year:2016 number:4 pages:1107 https://doi.org/10.1016/S0016-5085(16)33742-8 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ 42.15 Zellbiologie VZ AR 150 2016 4 1107 150.2016, 4, S1107- 045F 610 |
| allfieldsGer |
10.1016/S0016-5085(16)33742-8 doi GBVA2016021000021.pica (DE-627)ELV014578417 (ELSEVIER)S0016-5085(16)33742-8 DE-627 ger DE-627 rakwb 610 610 DE-600 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl Sato, Ken verfasserin aut Su1465 Elevated Serum Uric Acid Level Was a Notable Adverse Event of the Combination Therapy With Sofosbuvir and Ribavirin 2016 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Naganuma, Atsushi oth Nagashima, Tamon oth Horiuchi, Katsuhiko oth Hoshino, Takashi oth Arai, Yosuke oth Yuasa, Kazuhisa oth Uehara, Daisuke oth Hashizume, Hiroaki oth Kobayashi, Takeshi oth Ohyama, Tatsuya oth Horiguchi, Norio oth Yamazaki, Yuichi oth Kakizaki, Satoru oth Kusano, Motoyasu oth Yamada, Masanobu oth Enthalten in HighWire Press Leo, Manuela ELSEVIER Ubiquitin protease Ubp8 is necessary for 2018 official publication of the American Gastroenterological Association Stanford, Calif (DE-627)ELV000307017 volume:150 year:2016 number:4 pages:1107 https://doi.org/10.1016/S0016-5085(16)33742-8 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ 42.15 Zellbiologie VZ AR 150 2016 4 1107 150.2016, 4, S1107- 045F 610 |
| allfieldsSound |
10.1016/S0016-5085(16)33742-8 doi GBVA2016021000021.pica (DE-627)ELV014578417 (ELSEVIER)S0016-5085(16)33742-8 DE-627 ger DE-627 rakwb 610 610 DE-600 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl Sato, Ken verfasserin aut Su1465 Elevated Serum Uric Acid Level Was a Notable Adverse Event of the Combination Therapy With Sofosbuvir and Ribavirin 2016 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Naganuma, Atsushi oth Nagashima, Tamon oth Horiuchi, Katsuhiko oth Hoshino, Takashi oth Arai, Yosuke oth Yuasa, Kazuhisa oth Uehara, Daisuke oth Hashizume, Hiroaki oth Kobayashi, Takeshi oth Ohyama, Tatsuya oth Horiguchi, Norio oth Yamazaki, Yuichi oth Kakizaki, Satoru oth Kusano, Motoyasu oth Yamada, Masanobu oth Enthalten in HighWire Press Leo, Manuela ELSEVIER Ubiquitin protease Ubp8 is necessary for 2018 official publication of the American Gastroenterological Association Stanford, Calif (DE-627)ELV000307017 volume:150 year:2016 number:4 pages:1107 https://doi.org/10.1016/S0016-5085(16)33742-8 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ 42.15 Zellbiologie VZ AR 150 2016 4 1107 150.2016, 4, S1107- 045F 610 |
| source |
Enthalten in Ubiquitin protease Ubp8 is necessary for Stanford, Calif volume:150 year:2016 number:4 pages:1107 |
| sourceStr |
Enthalten in Ubiquitin protease Ubp8 is necessary for Stanford, Calif volume:150 year:2016 number:4 pages:1107 |
| format_phy_str_mv |
Article |
| bklname |
Biochemie: Allgemeines Biophysik Zellbiologie |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Ubiquitin protease Ubp8 is necessary for |
| authorswithroles_txt_mv |
Sato, Ken @@aut@@ Naganuma, Atsushi @@oth@@ Nagashima, Tamon @@oth@@ Horiuchi, Katsuhiko @@oth@@ Hoshino, Takashi @@oth@@ Arai, Yosuke @@oth@@ Yuasa, Kazuhisa @@oth@@ Uehara, Daisuke @@oth@@ Hashizume, Hiroaki @@oth@@ Kobayashi, Takeshi @@oth@@ Ohyama, Tatsuya @@oth@@ Horiguchi, Norio @@oth@@ Yamazaki, Yuichi @@oth@@ Kakizaki, Satoru @@oth@@ Kusano, Motoyasu @@oth@@ Yamada, Masanobu @@oth@@ |
| publishDateDaySort_date |
2016-01-01T00:00:00Z |
| hierarchy_top_id |
ELV000307017 |
| dewey-sort |
3610 |
| id |
ELV014578417 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV014578417</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623114632.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2016 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S0016-5085(16)33742-8</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016021000021.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV014578417</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0016-5085(16)33742-8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.70</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.12</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.15</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Sato, Ken</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Su1465 Elevated Serum Uric Acid Level Was a Notable Adverse Event of the Combination Therapy With Sofosbuvir and Ribavirin</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Naganuma, Atsushi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nagashima, Tamon</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Horiuchi, Katsuhiko</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hoshino, Takashi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Arai, Yosuke</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yuasa, Kazuhisa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Uehara, Daisuke</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hashizume, Hiroaki</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kobayashi, Takeshi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ohyama, Tatsuya</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Horiguchi, Norio</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yamazaki, Yuichi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kakizaki, Satoru</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kusano, Motoyasu</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yamada, Masanobu</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">HighWire Press</subfield><subfield code="a">Leo, Manuela ELSEVIER</subfield><subfield code="t">Ubiquitin protease Ubp8 is necessary for</subfield><subfield code="d">2018</subfield><subfield code="d">official publication of the American Gastroenterological Association</subfield><subfield code="g">Stanford, Calif</subfield><subfield code="w">(DE-627)ELV000307017</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:150</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:1107</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S0016-5085(16)33742-8</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.70</subfield><subfield code="j">Biochemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.12</subfield><subfield code="j">Biophysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.15</subfield><subfield code="j">Zellbiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">150</subfield><subfield code="j">2016</subfield><subfield code="e">4</subfield><subfield code="h">1107</subfield><subfield code="y">150.2016, 4, S1107-</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Sato, Ken |
| spellingShingle |
Sato, Ken ddc 610 ddc 570 fid BIODIV bkl 35.70 bkl 42.12 bkl 42.15 Su1465 Elevated Serum Uric Acid Level Was a Notable Adverse Event of the Combination Therapy With Sofosbuvir and Ribavirin |
| authorStr |
Sato, Ken |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000307017 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 570 - Life sciences; biology |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl Su1465 Elevated Serum Uric Acid Level Was a Notable Adverse Event of the Combination Therapy With Sofosbuvir and Ribavirin |
| topic |
ddc 610 ddc 570 fid BIODIV bkl 35.70 bkl 42.12 bkl 42.15 |
| topic_unstemmed |
ddc 610 ddc 570 fid BIODIV bkl 35.70 bkl 42.12 bkl 42.15 |
| topic_browse |
ddc 610 ddc 570 fid BIODIV bkl 35.70 bkl 42.12 bkl 42.15 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
a n an t n tn k h kh t h th y a ya k y ky d u du h h hh t k tk t o to n h nh y y yy s k sk m k mk m y my |
| hierarchy_parent_title |
Ubiquitin protease Ubp8 is necessary for |
| hierarchy_parent_id |
ELV000307017 |
| dewey-tens |
610 - Medicine & health 570 - Life sciences; biology |
| hierarchy_top_title |
Ubiquitin protease Ubp8 is necessary for |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV000307017 |
| title |
Su1465 Elevated Serum Uric Acid Level Was a Notable Adverse Event of the Combination Therapy With Sofosbuvir and Ribavirin |
| ctrlnum |
(DE-627)ELV014578417 (ELSEVIER)S0016-5085(16)33742-8 |
| title_full |
Su1465 Elevated Serum Uric Acid Level Was a Notable Adverse Event of the Combination Therapy With Sofosbuvir and Ribavirin |
| author_sort |
Sato, Ken |
| journal |
Ubiquitin protease Ubp8 is necessary for |
| journalStr |
Ubiquitin protease Ubp8 is necessary for |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 500 - Science |
| recordtype |
marc |
| publishDateSort |
2016 |
| contenttype_str_mv |
zzz |
| container_start_page |
1107 |
| author_browse |
Sato, Ken |
| container_volume |
150 |
| class |
610 610 DE-600 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Sato, Ken |
| doi_str_mv |
10.1016/S0016-5085(16)33742-8 |
| dewey-full |
610 570 |
| title_sort |
su1465 elevated serum uric acid level was a notable adverse event of the combination therapy with sofosbuvir and ribavirin |
| title_auth |
Su1465 Elevated Serum Uric Acid Level Was a Notable Adverse Event of the Combination Therapy With Sofosbuvir and Ribavirin |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA |
| container_issue |
4 |
| title_short |
Su1465 Elevated Serum Uric Acid Level Was a Notable Adverse Event of the Combination Therapy With Sofosbuvir and Ribavirin |
| url |
https://doi.org/10.1016/S0016-5085(16)33742-8 |
| remote_bool |
true |
| author2 |
Naganuma, Atsushi Nagashima, Tamon Horiuchi, Katsuhiko Hoshino, Takashi Arai, Yosuke Yuasa, Kazuhisa Uehara, Daisuke Hashizume, Hiroaki Kobayashi, Takeshi Ohyama, Tatsuya Horiguchi, Norio Yamazaki, Yuichi Kakizaki, Satoru Kusano, Motoyasu Yamada, Masanobu |
| author2Str |
Naganuma, Atsushi Nagashima, Tamon Horiuchi, Katsuhiko Hoshino, Takashi Arai, Yosuke Yuasa, Kazuhisa Uehara, Daisuke Hashizume, Hiroaki Kobayashi, Takeshi Ohyama, Tatsuya Horiguchi, Norio Yamazaki, Yuichi Kakizaki, Satoru Kusano, Motoyasu Yamada, Masanobu |
| ppnlink |
ELV000307017 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/S0016-5085(16)33742-8 |
| up_date |
2024-07-06T21:53:11.526Z |
| _version_ |
1803868219928215552 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV014578417</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623114632.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2016 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S0016-5085(16)33742-8</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016021000021.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV014578417</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0016-5085(16)33742-8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.70</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.12</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.15</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Sato, Ken</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Su1465 Elevated Serum Uric Acid Level Was a Notable Adverse Event of the Combination Therapy With Sofosbuvir and Ribavirin</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Naganuma, Atsushi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nagashima, Tamon</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Horiuchi, Katsuhiko</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hoshino, Takashi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Arai, Yosuke</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yuasa, Kazuhisa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Uehara, Daisuke</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hashizume, Hiroaki</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kobayashi, Takeshi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ohyama, Tatsuya</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Horiguchi, Norio</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yamazaki, Yuichi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kakizaki, Satoru</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kusano, Motoyasu</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yamada, Masanobu</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">HighWire Press</subfield><subfield code="a">Leo, Manuela ELSEVIER</subfield><subfield code="t">Ubiquitin protease Ubp8 is necessary for</subfield><subfield code="d">2018</subfield><subfield code="d">official publication of the American Gastroenterological Association</subfield><subfield code="g">Stanford, Calif</subfield><subfield code="w">(DE-627)ELV000307017</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:150</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:1107</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S0016-5085(16)33742-8</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.70</subfield><subfield code="j">Biochemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.12</subfield><subfield code="j">Biophysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.15</subfield><subfield code="j">Zellbiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">150</subfield><subfield code="j">2016</subfield><subfield code="e">4</subfield><subfield code="h">1107</subfield><subfield code="y">150.2016, 4, S1107-</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.400199 |